US 7534604
Fusion polypeptides capable of activating receptors
granted A61PA61P17/02A61P3/10
Quick answer
US patent 7534604 (Fusion polypeptides capable of activating receptors) held by REGENERON PHARMACEUTICALS, INC. expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P17/02, A61P3/10, A61P43/00, A61P9/00